Navigation Links
ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection)
Date:5/15/2008

INDIANAPOLIS, May 15 /PRNewswire-FirstCall/ -- Lung cancer patients whose histology is factored into treatment decisions may fare better as a result, according to data from a pivotal non-small cell lung cancer (NSCLC) clinical trial. Data from the trial, which involved Eli Lilly and Company's ALIMTA(R) (pemetrexed for injection), will be presented at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill., May 30 -- June 3, 2008.

"The data presented at ASCO confirms that histology matters when treating non-small cell lung cancer," said Richard Gaynor, M.D., vice president, cancer research and global oncology platform leader for Lilly. "We are seeing continued affirmation that when physicians factor in a patient's histology, pemetrexed becomes an even more valuable treatment option in non-small cell lung cancer."

Results from a multicenter, double-blind Phase III trial will be presented on June 2, 2008, at ASCO (Abstract # 8011). The study also was one of those featured during ASCO's live online presscast, a virtual press event that marked the first time researchers were invited to present key abstracts to the media prior to the annual meeting.

The trial compared the efficacy and safety of pemetrexed versus a placebo in 663 patients with stage IIIB/IV NSCLC whose disease had not progressed after four cycles of platinum-based induction chemotherapy. According to the results, patients treated with pemetrexed demonstrated increased efficacy with respect to progression-free survival compared to those treated by placebo (4.3 months vs. 2.6 months), and pemetrexed patients also achieved better tumor response (p < 0.001).

However, when data was broken down by histology, it was comparable to previous pemetrexed trials evaluating histology -- patients with a non-squamous histology fared better than those with a squamous histology. Patients with non-squamous histology who were treated with pemetrexed achie
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Study suggests blood test can help improve treatment outcomes for breast cancer patients
2. Study takes a step toward better defining fatigue
3. Having Less Power Impairs the Mind and Ability to Get Ahead, Study Shows
4. Study finds parents use cough medicines on under-2s despite the warnings
5. CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting
6. Study Supports Popular HIV Drug Regimen
7. Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals
8. Study shows that prostate cancer increases the risk of bone fracture
9. Study Suggests Green Tea May Support the Medical Treatment of Stomach and Colon Cancer
10. Forty-Five Percent of U.S. Employees Have Gained Weight at Their Current Jobs, CareerBuilder.com Study Finds
11. New Study: Texas Seniors 4th Hardest-Hit from Proposed Bush Administration Medicare Cuts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...clinical trial results could lead to availability ...reatment for deep lines and wrinkles by 2009. , ...y 24, 2008 -- Gel-Del Technologies , a St. Paul, ...d that it has concluded clinical trials of Cosmeta...ials say holds potential to be a more effective al...
(Date:7/23/2008)... the Financing Needs of European and A... YORK, July 24 /PRNewswire/ -- Paul Capital Partne...en promoted to Partner. Based in Paul,Capital,s Lo...ng,evaluating and negotiating European and Asian ...apital Healthcare funds., "Since he joined Paul C...
(Date:7/23/2008)...out-of-state intended parents, SAN RAMON, Calif.,...reme Court decision to allow gay couples to marry ...ence Center of the Bay Area (RSC), one of,the stat...nd lesbians for,infertility treatment., "Californ...C,s,long-held views that procreation is a natural ...
(Date:7/23/2008)...Call/ -- The Hanover Insurance Group,a leading su...announced it,is prepared to respond to claims resu...ugh southern Texas today., (Logo: http://www.new... are deeply concerned about individuals and busine...ent of The Hanover,s Central Region. "Our,staff is...
Breaking Medicine News(10 mins):Health News:Clinical Trial Concluded For New Wrinkle Treatment 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 3Health News:Paul Capital Partners Promotes Ken Macleod To Partner 2Health News:Paul Capital Partners Promotes Ken Macleod To Partner 3Health News:California Supreme Court Gay-Marriage Ruling Reinforces Top Bay Area Fertility Specialists' Support for Same-Sex Couples 2Health News:The Hanover Ready to Serve Policyholders Impacted by Hurricane Dolly 2
...der women suffering from chronic cytomegalovirus//...in life) were found to have more than triple the r... infection. This was reported in the Journal of th...time an association between CMV and frailty syndro...
...echnique to increase blood flow to the heart// tha...o increase 5 years of patients’ life than the coro...dical Center, US, have found that patients who had...eries have more life span when they undergo arteri...
...s with the help of seroquel is effective//, says a...bling mental illness. Some of the symptoms suffere...d, feelings of being persecuted, becoming withdraw...a can be treated symptomatically, but only one in ...
...od lower risk// of stroke.This link between childh... in a very interesting study published in the jour...n adults is not just due to exposure to risk facto...lated event over an entire lifetime. Previous stud...
Other Medicine News:Health News:Association between childhood diet and stroke 2
(Date:7/23/2008)...uly 23 /- Sound Pharmaceuticals (SPI)... with the FDA for the clinical,testing of a propri...,chemotherapy induced hearing loss or ototoxicity....ll be tested in advanced stage lung cancer,and hea...d chemotherapy.,This marks the second development ...
(Date:7/23/2008)...SCO, July 23 /- InCode BioPharmaceuti...oday announced preclinical test,results demonstrat... for,the treatment of the rare chronic blood disor... complete results will be presented at the XXII,In...and, September 28,2008., The only treatment curr...
(Date:7/22/2008)...fficacy results from a multi-center 293-patient Eu...onto Stock Exchange Symbol: CYT, MONTREAL, July 2...s,Inc., the global leader in cryotherapy products ... results previously presented from three,European ...ctic Front(R),were published earlier today in the...
(Date:7/22/2008)...strates Feasibility and Efficacy of Treating Patie...ncer, SAN FRANCISCO, and YONGIN-SI, South Korea, ...sco, CA and Ottawa, Ontario), and its South,Korean...ovel findings from,a Phase I clinical trial of its...hat the product was well-tolerated and resulted in...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4APHA Says Investing in Healthy People and Communities Can Help Create a Healthy Economy 10240 1APHA Says Investing in Healthy People and Communities Can Help Create a Healthy Economy 10240 2Cellix Ltd Launches the First Semi Automated High Throughput Cell Adhesion Assay Platform 2770 1Cellix Ltd Launches the First Semi Automated High Throughput Cell Adhesion Assay Platform 2770 2New study finds resistant organisms at core of soft contact lens corneal infections 10235 1New study finds resistant organisms at core of soft contact lens corneal infections 10235 2Alexion Pharmaceuticals Invites You to Participate in its Fourth Quarter and Full Year 2007 Results Conference Call and Web Cast 2766 1
...ne, the U.S.-based subsidiary of,Pharmexa A/S, pre...gram today at the Influenza Conference entitled, "...Toronto, Ontario, Canada. The,data show that a "un...immune responses can protect transgenic mice again..., HORSOLM, Denmark, June 21, 2007-Pharmexa-Epimmun...
... June 21, 2007 - “In anaplastic,astrocytoma,...erior,to temozolomide,” Prof. Albert Wong, M...nted on the international Phase,IIb study with the...by Antisense Pharma. Prof. Wong discussed the resu...on central nervous system tumors,at the 43rd Annua...
Other Medicine Technology:Pharmexa A/S (DK) - Pharmexa presents data from influenza program 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 3Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 4
...es, the Advantage Smart Table goes up to 6 inches ...h to accommodate all open procedures. Controlled w...sitions for various surgeons and procedures. One b...to level. The simple unidirectional set-up of the ...
Inquire
Liquichek Elevated CRP Control is a liquid assayed serum control with elevated levels of C-Reactive Protein.
Liquichek Cardiac Markers Plus Control is a premium, comprehensive cardiac assessment control with many analytes and long stability.
Medicine Products: